Literature DB >> 20036880

Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension.

Fernando A L Dias1, Dalia Urboniene, Milana A Yuzhakova, Brandon J Biesiadecki, James R Pena, Paul H Goldspink, David L Geenen, Beata M Wolska.   

Abstract

We investigated the role of inducible NOS (iNOS) on cardiac function during the development of left ventricular hypertrophy. Hypertrophy was induced by pressure-overload via short-term (2.5 months) or long-term (6.5 months) aortic banding (AoB) in wild-type (WT) and iNOS knock out (iNOSKO) mice. Cardiac function was then assessed via echocardiography, in situ hemodynamics and papillary muscle force measurements. Quantitative RT-PCR and Western blots were used to measure expression of hypertrophic gene markers and proteins respectively. Our data demonstrate that increased afterload via AoB leads to increased expression of iNOS that is associated with cardiac dysfunction. In pressure-overload induced hypertrophy, iNOSKO delays both the expression of hypertrophic markers and contractile dysfunction without causing significant changes in the level of hypertrophy. Moreover, after long-term AoB, iNOSKO animals exhibited increased basal cardiac function and an improved response to beta-adrenergic stimulation compared to long-term AoB WT animals. In conclusion, our data demonstrate that NO production via iNOS plays an important role in modulating cardiac function after moderate AoB that mimics long-term hypertension in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036880      PMCID: PMC2901916          DOI: 10.2741/e92

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  46 in total

1.  Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.

Authors:  Olga Gealekman; Zaid Abassi; Irit Rubinstein; Joseph Winaver; Ofer Binah
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 2.  Nitric oxide and cardiac function.

Authors:  R A Kelly; J L Balligand; T W Smith
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

3.  Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.

Authors:  Richard D Patten; David Denofrio; Mohamad El-Zaru; Rahul Kakkar; Jessica Saunders; Flore Celestin; Kenneth Warner; Hassan Rastegar; Kamal R Khabbaz; James E Udelson; Marvin A Konstam; Richard H Karas
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

4.  Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.

Authors:  Ying Sun; Oscar A Carretero; Jiang Xu; Nour-Eddine Rhaleb; Fangfei Wang; Chunxia Lin; James J Yang; Patrick J Pagano; Xiao-Ping Yang
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

5.  Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.

Authors:  I Fleming; B Fisslthaler; S Dimmeler; B E Kemp; R Busse
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

6.  Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.

Authors:  Yun-He Liu; Oscar A Carretero; Oscar H Cingolani; Tang-Dong Liao; Ying Sun; Jiang Xu; Lisa Y Li; Patrick J Pagano; James J Yang; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

7.  Deficiency of iNOS does not attenuate severe congestive heart failure in mice.

Authors:  Steven P Jones; James J M Greer; Paul D Ware; Jiang Yang; Kenneth Walsh; David J Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-19       Impact factor: 4.733

8.  Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.

Authors:  Ping Zhang; Xin Xu; Xinli Hu; Elza D van Deel; Guangshuo Zhu; Yingjie Chen
Journal:  Circ Res       Date:  2007-03-15       Impact factor: 17.367

9.  Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion.

Authors:  W J Paulus; P J Vantrimpont; A M Shah
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

10.  Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.

Authors:  M Fukuchi; S N Hussain; A Giaid
Journal:  Circulation       Date:  1998-07-14       Impact factor: 29.690

View more
  7 in total

1.  Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.

Authors:  Justin R Kingery; Tariq Hamid; Robert K Lewis; Mohamed Ameen Ismahil; Shyam S Bansal; Gregg Rokosh; Tim M Townes; Suzanne T Ildstad; Steven P Jones; Sumanth D Prabhu
Journal:  Basic Res Cardiol       Date:  2017-02-25       Impact factor: 17.165

2.  Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure.

Authors:  Sanja S Soskić; Branislava D Dobutović; Emina M Sudar; Milan M Obradović; Dragana M Nikolić; Jelena D Djordjevic; Djordje J Radak; Dimitri P Mikhailidis; Esma R Isenović
Journal:  Open Cardiovasc Med J       Date:  2011-07-07

3.  The ameliorating effects of long-term electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats.

Authors:  Ze-Jun Huo; Quan Li; Gui-Hua Tian; Chang-Man Zhou; Xiao-Hong Wei; Chun-Shui Pan; Lei Yang; Yan Bai; You-Yi Zhang; Ke He; Chuan-She Wang; Zhi-Gang Li; Jing-Yan Han
Journal:  BMC Complement Altern Med       Date:  2014-04-01       Impact factor: 3.659

Review 4.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

5.  Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension.

Authors:  Rahul B Dange; Deepmala Agarwal; Ryoichi Teruyama; Joseph Francis
Journal:  J Neuroinflammation       Date:  2015-02-18       Impact factor: 8.322

6.  Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats.

Authors:  Hong-Bao Li; Da-Nian Qin; Kang Cheng; Qing Su; Yu-Wang Miao; Jing Guo; Meng Zhang; Guo-Qing Zhu; Yu-Ming Kang
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

7.  Myocardial oxidative damage is induced by cardiac Fas-dependent and mitochondria-dependent apoptotic pathways in human cocaine-related overdose.

Authors:  Emanuela Turillazzi; Daniela Cerretani; Santina Cantatore; Anna Ida Fiaschi; Paola Frati; Lucia Micheli; Margherita Neri; Luigi Cipolloni; Marco Di Paolo; Enrica Pinchi; Irene Riezzo; Alessandro Santurro; Annamaria Vullo; Vittorio Fineschi
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.